Xiaopeng C. Peng

Key Laboratory Of Prevention And Treatment Of Cardiovascular And Cerebrovascular Diseases, Jiangxi Provincial Key Laboratory Of Tissue Engineering
Ganzhou, 341000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Discovery of novel quinazoline analogs as tubulin inhibitors targeting the colchicine binding site for potent antitumor therapy in combination with PD-L1 inhibitors.

Discovery of novel quinazoline analogs as tubulin inhibitors targeting the colchicine binding site for potent antitumor therapy in combination with PD-L1 inhibitors.

Journal: Bioorganic chemistry

Published: September 01, 2025

Correction to "Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging Opportunities".

Correction to "Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging Opportunities".

Journal: Journal of medicinal chemistry

Published: July 15, 2025

Discovery of Dual PD-L1/HDAC3 Inhibitors for Tumor Immunotherapy.

Discovery of Dual PD-L1/HDAC3 Inhibitors for Tumor Immunotherapy.

Journal: Journal of medicinal chemistry

Published: April 15, 2025

Decavanadate-Catalyzed Oxidative Cross-Dehydrogenative Coupling: an Efficient and Sustainable Approach toward P(O)─S Bond Formation.

Decavanadate-Catalyzed Oxidative Cross-Dehydrogenative Coupling: an Efficient and Sustainable Approach toward P(O)─S Bond Formation.

Journal: Angewandte Chemie (International ed. in English)

Published: March 31, 2025

Advances in molecular glue degraders for targeted protein degradation: Focus on NEK7, WEE1, CDK2, GSPT1 and VAV1.

Advances in molecular glue degraders for targeted protein degradation: Focus on NEK7, WEE1, CDK2, GSPT1 and VAV1.

Journal: Asian journal of pharmaceutical sciences

Published: March 26, 2025

Discovery of Novel and Highly Potent Dual PD-L1/Histone Deacetylase 6 Inhibitors with Favorable Pharmacokinetics for Cancer Immunotherapy.

Discovery of Novel and Highly Potent Dual PD-L1/Histone Deacetylase 6 Inhibitors with Favorable Pharmacokinetics for Cancer Immunotherapy.

Journal: Journal of medicinal chemistry

Published: February 20, 2025

Discovery of Highly Potent and Orally Bioavailable Histone Deacetylase 3 Inhibitors as Immunomodulators and Enhancers of DNA-Damage Response in Cancer Therapy.

Discovery of Highly Potent and Orally Bioavailable Histone Deacetylase 3 Inhibitors as Immunomodulators and Enhancers of DNA-Damage Response in Cancer Therapy.

Journal: Journal of medicinal chemistry

Published: January 28, 2025

Discovery of Novel Hydrazide-Based HDAC3 Inhibitors as Epigenetic Immunomodulators for Cancer Immunotherapy.

Discovery of Novel Hydrazide-Based HDAC3 Inhibitors as Epigenetic Immunomodulators for Cancer Immunotherapy.

Journal: Journal of medicinal chemistry

Published: January 23, 2025

Design, synthesis and bioevaluation of novel hydrazide derivatives as enhancers of immunotherapy and DNA-damage response in antitumor therapy.

Design, synthesis and bioevaluation of novel hydrazide derivatives as enhancers of immunotherapy and DNA-damage response in antitumor therapy.

Journal: European journal of medicinal chemistry

Published: December 25, 2024

Research progress in DNA damage response (DDR)-targeting modulators: From hits to clinical candidates.

Research progress in DNA damage response (DDR)-targeting modulators: From hits to clinical candidates.

Journal: European journal of medicinal chemistry

Published: December 25, 2024

Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma.

Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma.

Journal: Frontiers in molecular biosciences

Published: November 18, 2024

Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging Opportunities.

Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging Opportunities.

Journal: Journal of medicinal chemistry

Published: November 07, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026